Reducing Carbapenem Resistant Enterobacterales (CRE) Hospital Acquired Infections by Implementing a Prevention Bundle

被引：0
|
作者：
Dolan, B. [1 ]
Dawson, S. [1 ]
Lee, Y. [2 ]
Miyakawa, L. [3 ]
机构：
[1] Icahn Sch Med Mt Sinai, Dept Med, Mt Sinai Beth Israel, Internal Med, New York, NY USA
[2] Icahn Sch Med, Div Pulm & Crit Care, Dept Med, New York, NY USA
[3] Mt Sinai Beth Israel, Med Pulm & Crit Care, New York, NY USA
来源：
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE | 2024年 / 209卷
关键词：
D O I：
暂无
中图分类号：
R4 [临床医学];
学科分类号：
1002 ; 100602 ;
摘要：
A1518
引用
收藏
页数：2
相关论文
共 50 条
  • [31] Treatment for carbapenem-resistant Enterobacterales infections: recent advances and future directions
    Kathleen Tompkins
    David van Duin
    European Journal of Clinical Microbiology & Infectious Diseases, 2021, 40 : 2053 - 2068
  • [32] Diabetes Mellitus Association With Increased Mortality in Carbapenem-Resistant Enterobacterales Infections
    Aon, Mohamed
    Aoun, Ahmed H.
    Al Shami, Ahmad
    Alharbi, Abdulrahman
    Aljenfawi, Khaled
    Al-Anazi, Sarah
    Salman, Fares
    Assaf, Mohammed
    Mobarak, Magd
    Alroomi, Ebtehal
    Abdelwahab, Omar A.
    Ibrahim, Mohamed M.
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2024, 16 (02)
  • [33] Clinical characteristics and treatment outcomes of carbapenem-resistant Enterobacterales infections in Japan
    Oka, Keisuke
    Matsumoto, Akane
    Tetsuka, Nobuyuki
    Morioka, Hiroshi
    Iguchi, Mitsutaka
    Ishiguro, Nobuhisa
    Nagamori, Tsunehisa
    Takahashi, Satoshi
    Saito, Norihiro
    Tokuda, Koichi
    Igari, Hidetoshi
    Fujikura, Yuji
    Kato, Hideaki
    Kanai, Shinichiro
    Kusama, Fumiko
    Iwasaki, Hiromichi
    Furuhashi, Kazuki
    Baba, Hisashi
    Nagao, Miki
    Nakanishi, Masaki
    Kasahara, Kei
    Kakeya, Hiroshi
    Chikumi, Hiroki
    Ohge, Hiroki
    Azuma, Momoyo
    Tauchi, Hisamichi
    Shimono, Nobuyuki
    Hamada, Yohei
    Takajo, Ichiro
    Nakata, Hirotomo
    Kawamura, Hideki
    Fujita, Jiro
    Yagi, Tetsuya
    JOURNAL OF GLOBAL ANTIMICROBIAL RESISTANCE, 2022, 29 : 247 - 252
  • [34] Prevalence of carbapenem-resistant Enterobacterales (CRE) in Saudi Arabia: A systematic review and meta-analysis
    Alshehri, Ahmad A.
    Irekeola, Ahmad Adebayo
    SAUDI PHARMACEUTICAL JOURNAL, 2024, 32 (11)
  • [35] Increased carbapenemase testing following implementation of national VA guidelines for carbapenem-resistant Enterobacterales (CRE)
    Fitzpatrick, Margaret A.
    Suda, Katie J.
    Ramanathan, Swetha
    Wilson, Geneva
    Poggensee, Linda
    Evans, Martin
    Jones, Makoto M.
    Pfeiffer, Christopher D.
    Klutts, J. Stacey
    Perencevich, Eli
    Rubin, Michael
    Evans, Charlesnika T.
    ANTIMICROBIAL STEWARDSHIP & HEALTHCARE EPIDEMIOLOGY, 2022, 2 (01):
  • [36] The importance of active surveillance of carbapenem-resistant Enterobacterales (CRE) in colonization rates in critically ill patients
    Alves Gomides, Mabel Duarte
    de Souza Fontes, Astridia Marilia
    Soares Monteiro Silveira, Amanda Oliveira
    Matoso, Daniel Chadud
    Ferreira, Anderson Luiz
    Sadoyama, Geraldo
    PLOS ONE, 2022, 17 (01):
  • [37] Guidelines for prevention of hospital acquired infections
    Mehta, Yatin
    Gupta, Abhinav
    Todi, Subhash
    Myatra, S. N.
    Samaddar, D. P.
    Patil, Vijaya
    Bhattacharya, Pradip Kumar
    Ramasubban, Suresh
    INDIAN JOURNAL OF CRITICAL CARE MEDICINE, 2014, 18 (03) : 149 - 163
  • [38] Prevention of Hospital-Acquired Infections
    Dellinger, E. Patchen
    SURGICAL INFECTIONS, 2016, 17 (04) : 422 - 426
  • [39] Trimethoprim-sulfamethoxazole for the treatment of carbapenem-resistant Enterobacteriaceae (CRE) infections
    Bandali, Aiman
    Bias, Tiffany E.
    INFECTIOUS DISEASES, 2019, 51 (06) : 456 - 458
  • [40] Cefiderocol, a Siderophore Cephalosporin, as a Treatment Option for Infections Caused by Carbapenem-Resistant Enterobacterales
    Kaye, Keith S.
    Naas, Thierry
    Pogue, Jason M.
    Rossolini, Gian Maria
    INFECTIOUS DISEASES AND THERAPY, 2023, 12 (03) : 777 - 806
12345